Emergent BioSolutions (EBS) Non Operating Income (2011 - 2026)
Emergent BioSolutions (EBS) posted Non Operating Income of -$41.2 million for Q2 2026, compared with -$18.4 million a year earlier.
Emergent BioSolutions (EBS) Non Operating Income (2011 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Income at Emergent BioSolutions was -$80 million; for FY2025, it was -$17.3 million.
- In prior years, Emergent BioSolutions' Non Operating Income was -$34.2 million in FY2024, -$4.8 million in FY2023, -$49 million in FY2022 and -$38.2 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Non Operating Income since Q2 2024.
- According to Business Quant data, Non Operating Income for the three prior quarters was $2.9 million (Q1 2026), -$22.8 million (Q4 2025) and -$18.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,153.07 Bn | 1,121.65 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 624.88 Bn | 543.40 Bn | 17.26 Bn | - |
| 3 | AbbVie | 514.08 Bn | 487.19 Bn | 12.70 Bn | - |
| 4 | Merck | 366.14 Bn | 320.52 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.86 Bn | 261.85 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.47 Bn | 235.16 Bn | 12.86 Bn | - |
| 7 | Amgen | 235.14 Bn | 190.54 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 194.12 Bn | 168.32 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 172.20 Bn | 118.84 Bn | 10.94 Bn | - |
| 10 | Emergent BioSolutions | 322.24 Mn | -428.66 Mn | 137.20 Mn | -41.20 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -41.20 Mn |
| Mar 31, 2026 | 2.90 Mn |
| Dec 31, 2025 | -22.80 Mn |
| Sep 30, 2025 | -18.90 Mn |
| Jun 30, 2025 | -18.40 Mn |
| Mar 31, 2025 | 42.80 Mn |
| Dec 31, 2024 | -18.10 Mn |
| Sep 30, 2024 | 77.90 Mn |
| Jun 30, 2024 | -66.30 Mn |
| Mar 31, 2024 | -27.70 Mn |
| Dec 31, 2023 | -10.70 Mn |
| Sep 30, 2023 | -23.80 Mn |
| Jun 30, 2023 | 42.70 Mn |
| Mar 31, 2023 | -13.00 Mn |
| Dec 31, 2022 | -6.10 Mn |
| Sep 30, 2022 | -21.90 Mn |
| Jun 30, 2022 | -10.80 Mn |
| Mar 31, 2022 | -10.20 Mn |
| Dec 31, 2021 | -9.90 Mn |
| Sep 30, 2021 | -10.80 Mn |
Emergent BioSolutions Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=EBS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();